Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil

American Journal of Infection Control

Volumn 38, Issue 4, 2010, Pages 308-314

  Schimith Bier, Karina Eugênia ^a   Luiz, Simone Oliveira ^a   Scheffer, Mara Cristina ^a,b   Gales, Ana Cristina ^c   Paganini, Maria Cristina ^a,d   do Nascimento, Agnaldo José ^a   Carignano, Evelyn ^d   Dalla Costa, Libera Maria ^a,e  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE TUIUTI DO PARANÁ   (Brazil)

^e INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

Author keywords

Acinetobacter baumannii; carbapenem resistance; OXA 23

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; BRAZIL; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CATHETER INFECTION; CLINICAL FEATURE; CLONAL SPECIES; CONTROLLED STUDY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; DNA, BACTERIAL; FEMALE; GENE TRANSFER, HORIZONTAL; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77951974569     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.09.012     Document Type: Article

References (44)

1. Zarilli R., Crispino M., Bagattini M., Barretta E., Popolo A.D., Triassi M., et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 42 (2004) 946-953
2. Falagas M.E., and Kopterides P. Risk factors for the isolation of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64 (2006) 7-15
3. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., and Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51 (2007) 3471-3484
4. Livermore D.M. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs 3 (2002) 218-224
5. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27 (2006) 351-353
6. Wash T.R. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 21 (2008) 367-371
7. Brown S., and Amyes S. OXA β-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 51 (2006) 1-3
8. Kohlenberg A., Brummer S., Higgins P.G., Sohr D., Piening B.C., Grhal C., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical center. J Med Microbiol 58 (2009) 1499-1507
9. Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., and Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40, and -58 carbapenemases among Acinetobacter spp in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63 (2009) 55-59
10. Dalla Costa L.M., Coelho J.M., Souza H.A.P.M., Castro M.E., Stier C.J.N., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba. Brazil. J Clin Microbiol 41 (2003) 3403-3406
11. OXA-23 collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 34 (2009) 25-28
12. Martins A.F., Kuchenbecker R., Sukiennik T., Boff R., Reiter K.C., Lutz L., et al. Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil. Infection 37 (2009) 474-476
13. OXA-58 in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 3 (2008) 235-240
14. Villegas M.V., Kattan J.N., Correa A., Lolans K., Guzman A.M., Woodford N., et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob Agents Chemother 51 (2007) 2001-2004
15. York M.K., Schreckenberger P.C., and Miller J.M. In: Isenberg H.D. (Ed). Clinical microbiology procedures handbook. 2nd ed. Identification of gram-negative bacteria Vol 1 (2004), ASM Press, Washington, DC 3.18.2.1-.21
16. Horan T.C., Andrus M., and Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36 (2008) 309-332
17. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. 7th ed. (2006), Clinical and Laboratory Standards Institute, Wayne (PA)
18. Performance standards for antimicrobial susceptibility testing. M100-S16. 16th informational supplement (2006), Clinical and Laboratory Standards Institute, Wayne (PA)
19. Yong D., Lee K., Yum J.H., Shin H.B., Rossolini G.M., and Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp and Acinetobacter spp. J Clin Microbiol 40 (2002) 3798-3801
20. Sader H.S., Reis A.O., Silbert S., and Gales A.C. IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 11 (2005) 73-76
21. Gales A.C., Tognim M.C.B., Reis A.O., Jones R.N., and Sader H.S. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis 45 (2003) 77-79
22. Toleman M.A., Simm A.M., Murphy T.A., Gales A.C., Biedenbach D.J., Jones R.N., et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother 50 (2002) 673-679
23. Tsakris A., Pournaras S., Woodford N., Palepou M.F.I., Babini G., Douboyas J., and Livermore D.M. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 38 (2000) 1290-1292
24. Mendes R.E., Kiyota K.A., Monteiro J., Castanheira M., Andrade S.S., Gales A.C., et al. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 45 (2007) 544-547
25. Kaufmann M.E. Pulsed-field gel electrophoresis. In: Woodford N., and Johnson A.P. (Eds). Molecular bacteriology: protocols and clinical applications (1998), Humana Press, Totowa (NJ) 33-51
26. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
27. Haberman S.J. The analysis of residuals in cross-classified tables. Biometrics 29 (1973) 205-220
28. Poirel L., and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12 (2006) 826-836
29. Marqué S., Poirel L., Héritier C., Brisse S., Blasco M.D., Filip R., et al. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacilinase OXA-58 in Acinetobacter spp in Europe. J Clin Microbiol 43 (2005) 4885-4888
30. Valenzuela J.K., Thomas L., Partridge S.R., van der Reijden T., Dijkshoorn L., and Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 45 (2007) 453-460
31. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 43 (2005) 2241-2245
32. Yu Y.S., Yang Q., Xu X.W., Kong H.S., Xu G.Y., and Zhong B.Y. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol 53 (2004) 653-656
33. Hope R., Warner M., Mushtaq S., Ward M.E., Parsons T., and Livermore D.M. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 56 (2005) 1042-1046
34. Fernández-Mazarrasa C., Mazarrasa O., Calvo J., del Arco A., and Martínez-Martínez L. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline. J Clin Microbiol 47 (2009) 827-829
35. Danel F., Paetzel M., and Strynadka N.C. Effect of divalent metal cations on the dimerization of OXA-10 and-14 class D β-lactamases from Pseudomonas aeruginosa. Biochemistry 40 (2001) 9412-9420
36. Tognim M.C.B., Gales A.C., Penteado A., Silbert S., and Sader H.S. Dissemination of IMP-1 metallo-β-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol 27 (2006) 742-747
37. Tsakris A., Ikonomidis A., Pournaras S., Tzouvelekis L.S., Sofianou D., Legakis N.J., et al. VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerg Infect Dis 12 (2006) 981-983
38. Lee K., Yum J.H., Yong D., Lee H.M., Kim H.D., Docquier J.D., et al. Novel acquired metallo-ß-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49 (2005) 4485-4491
39. Lee N, Lee H, Ko N, et al. Impact of multidrug antimicrobial resistance on the health outcomes and economic burden in cases with Acinetobacter baumannii bacteremia. Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005. Abstract K1303. Washington, DC: American Society for Microbiology; 2005. p. 336.
40. Dijkshoorn L., Nemec A., and Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5 (2007) 939-951
41. Maragakis L.L., and Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46 (2008) 1254-1263
42. Naas T., Levy M., Hirschauer C., Marchandin H., and Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 43 (2005) 4826-4829
43. Zong Z., Xiaoju L., Valenzuela J.K., Partridge S.R., and Iredell J. An outbreak of carbapenen-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Inter J Antimicrob Agents 31 (2008) 50-54
44. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258 (2006) 72-77